Capital Medical Venture Whom To Approach For Funding

/in , /by

Capital medical venture or angel investor? Most entrepreneurs are confounded with this all-important question today. Who will invest money in their business or, more importantly which sort of investment should they approach? What would suit their business better?

Capital Medical Venture

A really good way of gauging this is by gauging your business venture. If you are confident of the ability of your business venture to provide good returns really soon, then go for venture capital firms. If you want to start large, then this is for you. These firms invest a whole lot of money, yes Im talking big money here their starting investment is five hundred thousand dollars and it goes into millions! But, they also charge a really high rate of interest more than twenty percent per annum. Plus you need to give them quick returns, which generally is not a problem in the medicine field.

A capital medical venture is a venture which is quite challenging to finance because it is a type of venture which requires an extensive expertise of the industry and a very, very methodical form of planning. The good news is nowadays, venture capital firms are actively on the lookout for companies like manufacturers of diagnostics, radiation systems of the intracoronary kind and surgical instruments which are minimally invasive. So if you are starting out on a business in the medical field, a capital medical venture, then this is the best time to start.

There are groups of venture capitalists who are very generous indeed and are willing to provide an entrepreneur with two hundred million dollars on (hold your breath!) a single transaction. What is more they are willing to consider many different kinds of investment structures such as management buyouts, recapitalizations which are leveraged, minority equity positions as well. So they are willing to be flexible.

Whom To Choose?

Coming back to the main point. What are the differences between an angel investor and a venture capital firm?

An angel investor generally has his own pricate money which he is willing to invest in a business. But a venture capitalist gets their money from a collection or rather, a group of wealthy individuals. Thus there is a big difference in the motivations of these two kinds of investors and the reasons behind why they invest.
A venture capital firms main motivation is to get good returns. Moreover, competition for their limited kind of funding is extremely keen. Many firms fund only about five companies out of say, every thousand business proposals they view per year so they are extremely cautious.

Angel investors have, on the other hand, experience in building a company. Sometimes, it gives them a high to invest in new startups and that is their sole reason for investment. Sometimes an idea catches their fancy and they invest for the heck of it.

A capital medical venture is often a risky business, so opting for an gel investor in this case is the best course of action for a new entrepreneur.

Are you planning to startup your Capital Medical Venture? Visit http://www.ventureworthy.com/capital_medical_venture.asp to get the latest tips, and helpful resources.

Find More Venture Capital Articles

Heidi Roizen, Mobius Venture Capital

/in , /by

Heidi Roizen, Mobius Venture Capital

In an interview with iinnovate, Heidi Roizen, renowned Silicon Valley venture capitalist and Managing Director of Mobius Venture Capital, talks about failure…
Video Rating: 4 / 5

Mount Sinai Makes Innovation a Team Effort At Its Second Annual Sinainnovations Conference, November 18-19, 2013 In NYC

/in , /by

New York, NY (PRWEB) November 13, 2013

The Icahn School of Medicine at Mount Sinai is hosting its second annual SINAInnovations event, and bringing together leaders from medicine, engineering, professional baseball, the performing arts, and the military to discuss the power of teamwork.

“SINAInnovations: Leading a New Era of Discovery,” will highlight the spirit of collaboration and explore how “team science” is leading to innovation and breakthroughs in biomedicine.

The conference will take place at Icahn School of Medicine’s Stern Auditorium at 1468 Madison Ave, on Monday, November 18 and Tuesday, November 19, 2013.

SINAInnovations is one of many ways in which Icahn School of Medicine is transforming academia and the fields of medical research, pharmacology, and technology. Mount Sinai has embarked upon an ambitious and unprecedented effort to redefine how collaborative innovation is taught, fostered, and facilitated within an academic institution. This year’s speakers cover a vast range of team-related topics and share strategies they have developed as leaders in areas such as academia, global media, and finance.

Keynote speakers include Nirav R. Shah, MD, Commissioner of Health, New York State, Joe Torre, Executive Vice President of Baseball Operation at Major League Baseball, Michael C. Crow, President of Arizona State University, Rear Admiral Scott P. Moore, Deputy Commander, Naval Special Warfare Command of the United States Navy, Gary S. May, Dean of the College of Engineering at Georgia Institute of Technology, and Sara Diamond, President of Ontario College of Art and Design.

Alice Park, Staff Writer at Time Magazine, Stephen H. Friend, President of Sage Bionetworks; Matthew VanBiesen, Executive Director of the New York Philharmonic; and Bhaven N. Sampat, Associate Professor of Health Policy and Management at Columbia University are among the prominent experts who will be featured during panel discussions and breakout sessions.

Distinguished Mount Sinai faculty members Dennis S. Charney, MD, Dean of Icahn School of Medicine at Mount Sinai, and Kenneth L. Davis, MD, Chief Executive Officer and President of the Mount Sinai Health System, will make presentations, along with leaders and researchers from Duke University Medical Center, Rensselear Polytechnic Institute, Northwestern University, University of Washington, GlaxoSmithKline, Novartis Venture Funds and Cook Ross, Inc.

“As an institution that places an emphasis on advancing research and best practices simultaneously, we consider Mount Sinai the ideal environment for the leaders of scientific progress to meet, collaborate, and ultimately determine the direction of biomedical and technological advancement. This year’s goal is to emphasize the creative and innovative advantages of team-centric culture,” said Dr. Charney, who is also President for Academic Affairs at the Mount Sinai Health System. “We are proud to continue the institution’s longstanding commitment to maximizing the very best of technology and innovation. Bringing renowned experts from academia, industry, venture capital, journalism and consultancy under one roof is our way of enabling further discoveries that will improve treatments for all patients.”

Scott L. Friedman, MD, Dean for Therapeutic Discovery at the Mount Sinai Health System added, “The rapid pace of discovery in biomedical science necessitates teamwork to achieve success. This year’s SINAInnovations conference will provide a playbook on team science, generating enthusiasm among attendees about implementing team science and creating the synergies that accelerate innovation.”

SINAInnovations is a forum-like atmosphere for investors and innovators from science, medicine, and industry and includes a networking session for trainees, sponsored by Mount Sinai’s Women in Science and Postdoctoral Fellows Association. SINAInnovations is open to biomedical professionals, Mount Sinai Faculty, trainees, and staff, as well as individuals from other academic medical centers. To learn more, visit http://www.mssm.edu/sinainnovations or email Sinainnovations(at)mssm(dot)edu.

SINAInnovations Agenda

Monday, November 18, 7:30 am to 5:00 pm

7:30 – 8:15 am: Breakfast/Registration

8:15 – 8:30 am: Welcoming Comments by Dennis S. Charney, MD

8:30 – 8:45 am: Special Opening Comments: Introduction, Dennis S. Charney, MD; Speaker: Nirav R. Shah, MD, MPH, Commissioner of Health, New York State

8:45 – 9:15 am: Keynote Address by Joe Torre, Executive Vice President, Baseball Operations, Major League Baseball

9:20 – 10:30 am: Panel Discussion: “The Psychology of Great Groups,” with Paul Holdengraber, Director of Public Programs at the New York Public Library; Michael Bierut, Partner, Pentagram; Gordon Edelstein, Artistic Director, Long Wharf Theatre; Jon Gertner, Author of ‘The Idea Factory’; Rosalyn Taylor O’Neale, Principal Consultant, Cook Ross, Inc.; Matthew VanBesien, Executive Director, New York Philharmonic.

10:30 – 11:00 am: Break

11:00 – 11:30 am: Keynote Address by Michael C. Crow, President Arizona State University

11:35 am – 12:30 pm: Panel Discussion “Team Science Success Stories,” with Alice Park, Staff Writer at Time Magazine, Stephen H. Friend, President, Co-founder and Director, Sage Bionetworks; Michael Goldblatt, President and CEO, Functional Genetics; W. David Lee, Executive in Residence, Kodiak Venture Partners; Michael Nielsen, Author of “Reinventing Discovery: The New Era of Networked Science”; John Stamatoyannopoulos, Associate Professor, Genome Sciences and Medicine, University of Washington

12:30 – 1:00 pm: Pick Up Lunch at Breakout Room

1:00 – 2:00 pm: Breakout Sessions With Lunch on “Scholarship in Team Science,” with Noshir Contractor, Professor and Director of SONIC Research Group, Northwestern University; Annetine Gelijns, Professor and Chair of Health Evidence and Policy, Mount Sinai Health System; Richard Nelson, Director of the Program on Science, Technology, and Global Development, Columbia University; “Diversity in the Context of Team Science,” Rosalyn Taylor O’Neale, Principal Consultant at Cook Ross, Inc.; “Mount Sinai RPI Technology Development Team,” Gavin McIntyre, Co-founder and Chief Scientist at Evocative Design; Student QED projects; 4D projects; “Divergent Environments for Team Science? Industry vs. Academia,” Steven H. Friend, President of Sage Bionetworks; and Michael Goldblatt, CEO of Functional Genetics

2:30-5:00 pm: Networking Reception for Trainees in the Davis Conference Center, 2nd Floor, Hess CSM, Sponsored by Women in Science and Postdoctoral Fellows Association

Tuesday, November 19, 7:30 am to 12:15 pm

7:30 – 8:15 am: Breakfast/ Registration

8:30 – 9:00 am: Keynote Address by Rear Admiral Scott P. Moore, Deputy Commander, Naval Special Warfare Command, United States Navy, “Teamwork – A Life and Death Necessity”

9:05 – 10:30 am: Panel Discussion: “Team Science in Academic Medical Centers and Pharma with Bhaven. N. Sampat, Associate Professor, Health Policy and Management, Columbia University; Noshir Contractor, Professor and Director of SONIC Research Group, Northwestern University; Jonathan S. Dordick, Vice President for Research and Howard P. Isermann Professor of Chemical and Biological Engineering, Rensselaer Polytechnic Institute; Anja König, Managing Director, Novartis Venture Fund; John. J. Lepore, Vice President of the Heart Failure Discovery Performance Unit, GlaxoSmithKline; Peter K. Smith, Division Chief of Cardiovascular and Thoracic Surgery, Duke University Medical Center

10:30 – 11:55 am: Break

11:00 – 11:30 am: Keynote Address by Gary S. May, Dean of the College of Engineering, Georgia Institute of Technology

11:30 am – 12:00 pm: Keynote Address by Sara Diamond, President of Ontario College of Art and Design

12:00 – 12:15 pm: Closing Remarks: “The Power of Team Science,” Kenneth L. Davis

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.

For more information, visit Mount Sinai on the web, Facebook, Twitter or YouTube.







Find More Venture Capital Press Releases

Website Developers Mark Decade of Stunning Change and Growth

/in , /by


Buchanan, Michigan (PRWEB) November 14, 2013

The website developers at Precept Partners recently passed the ten year mark since launching their consultancy in 2003. Company principals noted fundamental changes over the past decade in Internet technology, marketing methods and business models driving growth and change in the online channel.

With offices in the Buchanan (Michigan) Museum of Fine Art, Precept Partners provide Internet strategies, website design, development and online marketing services to clients in e-commerce, retail, manufacturing, high-tech, the arts and not-for-profit sectors, with combined online sales of over $ 100,000,000 to their credit.

Precept’s manager, Stephen Antisdel said, “We launched the company shortly after selling our first Internet business to a venture capital firm. Looking back to 2003, the Internet was a different world then; there was no Twitter or Facebook; no YouTube, no Apple iPhones; Google was still privately held and Amazon’s sales were 1/10th of what they are today. In just ten years these businesses have grown to a combined market cap of over a trillion dollars; they’ve fundamentally changed the landscape of the Internet as a place to do business.”

“The shift from desktop computers to tablets and mobile devices has changed the calculus for website design, keyword advertising and search engine optimization,” added Jeffrey Antisdel, the company’s co-founder. “At the same time, online video and social media have experienced exponential growth in users and the time people are spending online in these channels.”

“Over the last ten years, we’ve responded to these changes with fully responsive website design, data driven online marketing, and new services, including video production. It’s been gratifying to help our clients thrive and grow through this decade of rapid, accelerating change,” concluded Antisdel.

About Precept Partners:

Precept Partners provides award winning website design, development and online marketing services proven by more than $ 100MM in online sales. Launched in 2003, Precept today serves clients in e-commerce, manufacturing, technology, the arts, and not-for-profit sectors. Media recognition for Precept’s principals includes The Wall Street Journal, BusinessWeek, Investors’ Business Daily, Business 2.0, Furniture Today, and NPR. Client awards include the Inc. 500, the Internet Retailer 500, the Hot 100 Best Retail Websites, the Webby Award for website design and many others. For more information visit http://www.PreceptPartners.com.







Hypo Venture Capital Asset Allocation: A Sound Investment Strategy Part 2

/in , /by

Here at Hypo Venture Capital we are committed to offering our clients access to the latest and broadest range of financial services and products on the market. We know that choosing the right strategy, the right investment and the right product is no easy task in this day and age! Whether its advice, investments or financial planning we are here to answer all your questions and facilitate all your financial needs.

In today’s complex financial markets, you have an impressive array of investment vehicles from which to select. Each investment also carries some risks, making it important to choose wisely if you are selecting just one.

The good news is that there’s no rule that says you must stick with only one type of investment. In fact, you can potentially lower your investment risk and increase your chances of meeting your investment goals by practicing “asset allocation.”

Asset Allocation Can Work

For instance, at age 25 you may decide to invest with the goal of retiring in comfort within 40 years. Most likely, your investment goal is to achieve as much growth as possible — growth that will outpace inflation substantially. In aiming to reach this goal, you may allocate 70% of your assets into aggressive growth stocks, 20% into bonds, and 10% into money market instruments. You have years to ride out the wide fluctuations that come with stocks, but at the same time, you potentially lower your risk with your bond and money market holdings.

Because your goals and circumstances are unique, you may want to talk with an investment advisor who can help you tailor an allocation strategy for your needs. Generally, your asset allocation will change as you reach different stages in your life, as your investment goals also change along with these shifts in lifestyle.

If you have been investing aggressively for retirement for more than 20 years and are now less than 10 years from retiring, protecting what your investment may have earned from market ups and downs may become more important. In this case you may want to gradually shift some of your stock allocation into your bond and money market holdings. Keep in mind, however, that many financial experts recommend that stocks be considered for every portfolio to maintain growth potential.

A Simple Process, Some Dramatic Potential Results

Asset allocation is a simple concept, yet vital to long-term investment success. In fact, a landmark study cited in Financial Analysts Journal shows that about 90% of the variability of average total returns earned by balanced mutual funds and pension plans over time was the result of asset allocation policy.3 For many individual investors, the asset allocation decision amounts to choosing what types of mutual funds to invest in and the amount to invest in each type of fund. Others may want to add individual securities to this mix after exploring their investment options.

Regardless of the asset allocation strategy you choose and the investments you select, keep in mind that a well-crafted plan of action over the long term can help you weather all sorts of changing market conditions as you aim to meet your investment goal(s).

Points to Remember

1. Asset allocation is the way in which you spread your investment portfolio among different asset classes, such as stocks and stock mutual funds, bonds, and bond mutual funds.

2. When prices of different types of assets do not move in tandem, combining these investments in a portfolio can help reduce the variability of returns, commonly referred to as “market risk.”

3. Mutual funds are pools of securities, usually offering diversification within a single asset class. Some mutual funds may include several asset classes.

4. The asset allocation that is right for you depends on your investment time frame, goals, and tolerance for risk.

5. As your investment time frame and goals change, so might your asset allocation. Many financial experts suggest reevaluating your asset allocation periodically or whenever you experience a milestone event in your life such as marriage, the birth of a child, or retirement.

Want to know more?

Hypo Venture Capital is an independent investment advisory firm which focuses on global equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. All views, comments, statements and opinions are of the authors. For more information go to www.hypovc.com

Hypo Venture Capital is an independent investment advisory firm which focuses on global equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. All views, comments, statements and opinions are of the authors. For more information go to www.hypovc.com

More Venture Capital Articles

Vertical Consultants Reveals How Q3 2013 Mobile Investments Affect Cell Tower Landlords

/in , /by


Nashville, TN (PRWEB) November 14, 2013

Mobile venture capital investments have reached the largest financing quarter in history, according to CB Insights, a trusted investment database company. Venture capital firms have capitalized on the demand for apps, devices, mobile video, and mobile advertising among others, by investing over $ 1.12B in US mobile-related companies. This has made the third quarter of 2013 the highest quarterly total on record. It was also the first time that venture capital mobile deals have surpassed the healthcare sector.

These companies’ profit margins are on the rise, and, unfortunately, cell tower landlords are often not privy to this information. Implementing supply and demand economics would allow property owners to be paid full and fair value for telecoms and tower developers’ use of their land. As demand for mobile connectivity rises [subsequently increasing cell towers’ revenue] the value of property owners’ cell tower leases and the land used for telecom purposes also rises.

Hugh Odom, President and Founder of Vertical Consultants states, “Property owners throughout North America are in a better position today than ever before when it comes to negotiating terms for telecoms’ and tower developers’ use of their property. Growing consumer demands for mobile connectivity, in addition to an array of other mobile demands, increases the value of cell towers and their leases. However, property owners do not take advantage of this value increase because they are unaware that it even exists. Vertical Consultants was established to inform the uniformed property owners, advocating for those landowners who have been taken for granted and getting them full and fair value for their land that they deserve.”

Vertical Consultants’ success in the industry has proven the wide disparity between property owners and telecom companies. In 2012, the telecom lease-consulting firm increased property owners’ cell tower rents by 142% and, since inception, has recovered over 200 years worth of unpaid cell tower rents and expenses for their clients, collectively.

Vertical Consultants was founded in 2010 by Hugh Odom and is comprised of wireless industry veterans with decades of combined experience. Vertical Consultants specializes in issues surrounding the wireless telecom industry and prides itself as a source of information for property owners. Vertical Consultants experience in the industry allows it to offer its clients unmatched expertise, services and results. Unlike others in their field, Vertical Consultants is able to handle every aspect of the issues surrounding a cell tower, rooftop or any other type of telecom lease, from start to finish. To learn more, visit http://www.vertical-consultants.com or contact Vertical Consultants at info(at)vertical-consultants.com or 877.456.7552.







Find More Venture Capital Press Releases

Venture Capital Intevestments For Consumer Brands Development

/in , /by

Venture capital will be ordinarily offered from the venture capitalists and also the professionals who invest money inside young, speedily developing companies that have the possibilities to be able to come to be considerable economic contributors. Its best option intended for businesses along with great up-front capital prerequisites which often cannot be financed by simply cheaper alternatives such as debt. These types of venture capital firms are actually the private close ties that are funded by simply private along with public cash, endowment cash, foundations, corporations, well-to-do persons and also foreign investors. These types of venture funds may usually use up these types of assignments -financing new along with speedily developing companies, aiding the development connected with new products and also services, purchase equity securities, increase value to the company via lively involvement and also have better risks while using expectation connected with better returns. Although taking into consideration company intended for capital investment, these types of venture capitalists properly screen the practical along with business merits from the proposed company which is presented comprising business plan to be able to these people.

The forms of venture cash usually offered from the venture capitalists and so are currently considering are generally consumer product venture funds such as health care venture cash, education venture funds, residence along with personal care venture funds, retail venture cash along with venture cash intended for business such as computers, software, networking along with FMCG venture fund.   Whatsoever will be the industry, business will be relevant along with, brand is essential since it helps to produce the consumer be connected essential to build long-term, developing businesses. A number entrepreneurs do not have sufficient cash to be able to finance projects by themselves, and they must as a result look for in the garden university. Intended for Branding Advertising claims to be an crucial issue and then for this place must invest massive amount money. There are a few Indian venture cash that will offer venture capital intended for brand promotion along with advertising media inputs intended for business growth. The firms such as Times group private treaties significant other while using investee companies compliment these people inside making consumer brand value along with inside return the investee gives shares and also an integral part of business control to the investors.

Morpheus India is an Indian venture fund that provides venture funds for Indian consumer brands, Morpheus investing in mid-sized company as FMCG venture funds such as education venture fund and healthcare venture fund, Morpheus capital venture fund for specialty retail sectors.

This week we have Howard Morgan, managing partner, First Round Capital. For more information, show notes, and an upcoming schedule, go to www.thisweekin.com.
Video Rating: 5 / 5

Related Venture Capital Articles

Dev Ittycheria Joins OpenView Venture Partners

/in , /by


Boston, MA (PRWEB) November 13, 2013

OpenView Venture Partners, an expansion-stage venture capital firm focused on providing technology companies with deep operational support, today welcomes enterprise software expert Dev Ittycheria as the firm’s third Managing Director. Ittycheria joins the firm after a successful track record of building and scaling world-class software companies as a founder, CEO, senior executive, investor, and board member. He will concentrate on helping identify and invest in the best expansion-stage technology companies.

“We are thrilled to welcome Dev to the OpenView team,” said Scott Maxwell, OpenView’s Founder and Senior Managing Director. “His strong background in entrepreneurship, combined with his deep operational experience and his knowledge of cloud, SaaS, and enabling IT infrastructure, will make Dev a very valuable addition to the firm.”

Prior to joining OpenView, Ittycheria was a venture partner at Greylock Partners, where he spent time learning the venture business at the leading early stage venture capital firm in Silicon Valley. Earlier, Ittycheria was the president of BMC Software, where he and his team radically transformed a maturing business to outperform the competition on all meaningful financial metrics. Before that, as the co-founder, president, and CEO, Ittycheria built BladeLogic, a next-generation systems management company, into one of the fastest-growing enterprise software companies of the last decade. The company went public in 2007 and was acquired by BMC in 2008. Ittycheria was also previously a co-founder and CEO of one of the first venture-backed cloud computing companies.

In addition to identifying new investments at OpenView, Ittycheria will also leverage his operational and leadership skills to help the firm scale for the next level of growth.

“I’m very excited to join OpenView,” said Ittycheria. “It’s a dynamic firm that has done a terrific job of differentiating itself in the industry because of its sharp focus on expansion-stage technology companies and unique team of full-time, value-add consultants. I believe OpenView is extremely well positioned to dominate an important investment category over the coming years.”

Ittycheria’s arrival continues the ongoing expansion of OpenView’s investment team. In August, the firm also welcomed Mackey Craven as an Associate from Bessemer Venture Partners, followed by Blake Bartlett, who joined as a Vice President from Battery Venture Partners in November. The team’s growth underscores the firm’s strong belief in the future of enterprise SaaS businesses.

Founded in 2006, OpenView raised its third fund in March 2012 and has since invested in five new SaaS companies. This week, the firm also launched a completely redesigned version of its website, available at http://www.openviewpartners.com.

About OpenView Venture Partners

OpenView Venture Partners is an expansion-stage venture capital fund based in Boston that is focused on high-growth software, Internet, and technology-enabled companies. Through its staff of seasoned operating executives, who collectively bring several decades of technology and management experience to the firm, OpenView is able to help portfolio companies quickly optimize their product, go-to-market, and organizational and operational functions. Founded in 2006, the firm invests globally and has approximately $ 445 million in total capital under management.







More Venture Capital Press Releases

Hypo Venture Capital Asset Allocation: A Sound Investment Strategy Part 2

/in , /by

Here at Hypo Venture Capital we are committed to offering our clients access to the latest and broadest range of financial services and products on the market. We know that choosing the right strategy, the right investment and the right product is no easy task in this day and age! Whether its advice, investments or financial planning we are here to answer all your questions and facilitate all your financial needs.

In today’s complex financial markets, you have an impressive array of investment vehicles from which to select. Each investment also carries some risks, making it important to choose wisely if you are selecting just one.

The good news is that there’s no rule that says you must stick with only one type of investment. In fact, you can potentially lower your investment risk and increase your chances of meeting your investment goals by practicing “asset allocation.”

Asset Allocation Can Work

For instance, at age 25 you may decide to invest with the goal of retiring in comfort within 40 years. Most likely, your investment goal is to achieve as much growth as possible — growth that will outpace inflation substantially. In aiming to reach this goal, you may allocate 70% of your assets into aggressive growth stocks, 20% into bonds, and 10% into money market instruments. You have years to ride out the wide fluctuations that come with stocks, but at the same time, you potentially lower your risk with your bond and money market holdings.

Because your goals and circumstances are unique, you may want to talk with an investment advisor who can help you tailor an allocation strategy for your needs. Generally, your asset allocation will change as you reach different stages in your life, as your investment goals also change along with these shifts in lifestyle.

If you have been investing aggressively for retirement for more than 20 years and are now less than 10 years from retiring, protecting what your investment may have earned from market ups and downs may become more important. In this case you may want to gradually shift some of your stock allocation into your bond and money market holdings. Keep in mind, however, that many financial experts recommend that stocks be considered for every portfolio to maintain growth potential.

A Simple Process, Some Dramatic Potential Results

Asset allocation is a simple concept, yet vital to long-term investment success. In fact, a landmark study cited in Financial Analysts Journal shows that about 90% of the variability of average total returns earned by balanced mutual funds and pension plans over time was the result of asset allocation policy.3 For many individual investors, the asset allocation decision amounts to choosing what types of mutual funds to invest in and the amount to invest in each type of fund. Others may want to add individual securities to this mix after exploring their investment options.

Regardless of the asset allocation strategy you choose and the investments you select, keep in mind that a well-crafted plan of action over the long term can help you weather all sorts of changing market conditions as you aim to meet your investment goal(s).

Points to Remember

1. Asset allocation is the way in which you spread your investment portfolio among different asset classes, such as stocks and stock mutual funds, bonds, and bond mutual funds.

2. When prices of different types of assets do not move in tandem, combining these investments in a portfolio can help reduce the variability of returns, commonly referred to as “market risk.”

3. Mutual funds are pools of securities, usually offering diversification within a single asset class. Some mutual funds may include several asset classes.

4. The asset allocation that is right for you depends on your investment time frame, goals, and tolerance for risk.

5. As your investment time frame and goals change, so might your asset allocation. Many financial experts suggest reevaluating your asset allocation periodically or whenever you experience a milestone event in your life such as marriage, the birth of a child, or retirement.

Want to know more?

Hypo Venture Capital is an independent investment advisory firm which focuses on global equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. All views, comments, statements and opinions are of the authors. For more information go to www.hypovc.com

Hypo Venture Capital is an independent investment advisory firm which focuses on global equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. All views, comments, statements and opinions are of the authors. For more information go to www.hypovc.com

Find More Venture Capital Articles

Email Management Solution Gets Funding Boost

/in , /by


(PRWEB) March 26, 2012

KnowledgeMills OnePlace cloud and on-premise solution makes the classification of emails and documents a natural part of Outlook and Office, and gives collaborative workers a shared single file for any customer, project or legal matter without ever leaving the familiar environs of Outlook and Office. The user task of filing is reduced by over 90% through self-filing emails and intelligent tagging, and IT overhead is dramatically reduced by separating information rich business emails from disposable emails.

Founded in 2009 by content management experts from some of the worlds largest law firms, KnowledgeMills enterprise grade software can handle 10,000s of users, asynchronously filing emails to avoid performance hits, and works seamlessly with existing document management infrastructure to add effective handling of todays very high volume of information rich emails. KnowledgeMill currently partners with Oracle, EMC, Microsoft and Fujitsu to service enterprise customers.

KnowledgeMill CEO Hisham Anis said We have transformed Outlook to accommodate the fact that email is the de-facto dominant store of documents and business information for businesses today, and this funding and expansion of resources signals that we are building a world-leading business around that innovation. Its great to bring experienced venture capital providers such as Seraphim and MMC into our team he added.

The company underlined its ambitions with the appointment of Peter Norman as Executive Chairman. A veteran of British technology success stories Psion PLC and Sophos PLC, Peter said KnowledgeMill have an extraordinary opportunity to reverse the fragmentation of filing that happened with the explosion of email, by bringing into Outlook the underlying concept of single shared storage without the user compromising on flexibility or even having to consciously file 80% of their business correspondence. He added My job is to help guide them to rapidly build a world leading business from this significant product technology.

For further information, contact:

Hishram Anis on 07717 542847, hisham.anis(at)knowledgemill(dot)com

Peter Norman on 07720 291949, peter.norman(at)knowledgemill(dot)com

Notes to Editors:

About KnowledgeMill

KnowledgeMills (http://www.knowledgemill.com) OnePlace software provides a unique level of email management for collaborative workers in large and medium size enterprises. Designed to cope with todays high volume, email-centric style of working, OnePlace automatically files emails and documents in folders that are shared between users, all from within Outlook in order not to disrupt established working habits. OnePlace separates key business data from disposable emails, directly addressing the many problems of email bloat, from efficient retrieval to efficient storage and archiving.

About MMC Ventures

MMC Ventures (http://www.mmcventures.com) is an active investor, dedicated to backing entrepreneurs to create valuable companies. Founded in 2000, they currently have